Joan Fort
Overview
Explore the profile of Joan Fort including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
405
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Locatelli F, Karaboyas A, Pisoni R, Robinson B, Fort J, Vanholder R, et al.
Nephrol Dial Transplant
. 2017 Oct;
33(4):683-689.
PMID: 29040687
Background: With its convective component, hemodiafiltration (HDF) provides better middle molecule clearance compared with hemodialysis (HD) and is postulated to improve survival. A previous analysis of Dialysis Outcomes and Practice...
2.
Baneras J, Buera I, Oristrell G, Sansano I, Fort J, Ibernon M, et al.
Int J Cardiol
. 2015 Oct;
202:485-7.
PMID: 26440456
No abstract available.
3.
Espinel E, Agraz I, Ibernon M, Ramos N, Fort J, Seron D
J Clin Med
. 2015 Aug;
4(5):998-1009.
PMID: 26239461
The majority of diabetic patients with renal involvement are not biopsied. Studies evaluating histological findings in renal biopsies performed in diabetic patients have shown that approximately one third of the...
4.
Martinez-Castelao A, Cases A, Coll E, Bonal J, Galceran J, Fort J, et al.
Nefrologia
. 2014 Oct;
35(1):80-6.
PMID: 25349927
Background And Objective: C.E.R.A. (continuous erythropoietin receptor activator, pegilated-rHuEPO ß) corrects and maintains stable hemoglobin levels in once-monthly administration in chronic kidney disease (CKD) patients. The aim of this study...
5.
Azancot M, Ramos N, Moreso F, Ibernon M, Espinel E, Torres I, et al.
Transplantation
. 2014 Apr;
98(5):537-42.
PMID: 24770618
Background: Hypertension is one of the most prevalent cardiovascular risk factors in chronic kidney disease (CKD) and kidney transplants. The contribution of transplantation to hypertension in comparison to patients with...
6.
Espinel E, Joven J, Gil I, Sune P, Renedo B, Fort J, et al.
BMC Res Notes
. 2013 Aug;
6:306.
PMID: 23915518
Background: Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are renoprotective but both may increase serum potassium concentrations in patients with chronic kidney disease (CKD). The proportion of affected patients,...
7.
Jatem E, Agraz I, Semidei M, Ferrer B, Ramos R, Fort J
Nefrologia
. 2013 Jul;
33(4):608-9.
PMID: 23897199
No abstract available.
8.
Robinson B, Zhang J, Morgenstern H, Bradbury B, Ng L, McCullough K, et al.
Kidney Int
. 2013 Jun;
85(1):158-65.
PMID: 23802192
Mortality rates for maintenance hemodialysis patients are much higher than the general population and are even greater soon after starting dialysis. Here we analyzed mortality patterns in 86,886 patients in...
9.
Perl J, Zhang J, Gillespie B, Wikstrom B, Fort J, Hasegawa T, et al.
Nephrol Dial Transplant
. 2012 Oct;
27(12):4464-72.
PMID: 23028105
Background: Although dialysis after kidney transplant failure (TF) is common, the outcomes of these patients remain unclear. We compared outcomes of TF patients with transplant-naïve (TN) patients wait-listed for kidney...
10.
Locatelli F, Stefoni S, Petitclerc T, Coli L, di Filippo S, Andrulli S, et al.
Nephrol Dial Transplant
. 2012 May;
27(10):3935-42.
PMID: 22561583
Background: Intradialytic hypotension (IDH) is still a major clinical problem for haemodialysis (HD) patients. Haemodiafiltration (HDF) has been shown to be able to reduce the incidence of IDH. Methods: Fifty...